
Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development. In this role, Kolia will …
How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …
UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

